Science 37 Holdings

Science 37 Holdings, Inc. provides technology-based solutions that enables decentralized clinical trials. The company is headquartered in Durham, NC.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

ISO 27001 certification and ISO 27701:2019 extension demonstrate Science 37's commitment to quality, cybersecurity and privacy management ISO 27001 certification and ISO 27701:2019 extension demonstrate Science 37's commitment to quality, cybersecurity and privacy management

Science 37®'s Operating System Receives ISO Certification for Information Security Management

RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System™, today announced the company will be participating in the upcoming Cowen 42nd Annual Health Care Conference.

Science 37® to Present at the Cowen 42nd Annual Health Care Conference

Since January 2021, Science 37's community provider network has added nearly 35,000 physician-providers to enable agile clinical trial execution. Since January 2021, Science 37's community provider network has added nearly 35,000 physician-providers to enable agile clinical trial execution.

Science 37®'s Community Provider Network Grows Sixfold, Reaching Nearly 28 Million Patients

Collaboration will yield objective, predictive, and real-time digital measures—supplementing clinical trial digital endpoints collected from biosensors Collaboration will yield objective, predictive, and real-time digital measures—supplementing clinical trial digital endpoints collected from biosensors

Science 37® and physIQ Collaborate to Enhance Clinical Trial Data Collected from Connected Devices

Science 37's Operating System to enhance Worldwide Clinical Trials' approach to decentralized clinical trials for faster enrollment, better retention, and more representative solutions Science 37's Operating System to enhance Worldwide Clinical Trials' approach to decentralized clinical trials for faster enrollment, better retention, and more representative solutions

Worldwide Clinical Trials and Science 37® Partner to Advance Agile Clinical Trials™ and Accelerate Study Timelines

Science 37 enhances its Operating Systems, adding ability to deploy its technology platform into China and Russia and strengthening global capabilities to execute clinical trials and accelerate development Science 37 enhances its Operating Systems, adding ability to deploy its technology platform into China and Russia and strengthening global capabilities to execute clinical trials and accelerate development

Science 37® Furthers Global Expansion with Capabilities in China and Russia to Advance Decentralized Clinical Trials and Accelerate Development

New data suggest that, for the first time, research sponsors and CROs plan to run more agile or hybrid clinical trials than traditional, site-based studies New data suggest that, for the first time, research sponsors and CROs plan to run more agile or hybrid clinical trials than traditional, site-based studies

Science 37® Reveals a Pivotal Shift in the Clinical Trials Landscape

LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Operating System for today's more agile clinical trials, today reported its financial results for the quarter ended September 30, 2021.

Science 37 Reports Quarterly Financial Results for the Period Ended September 30, 2021

LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Operating System for today's more agile clinical trials, today announced it will report third quarter 2021 financial results before the market opens on Monday, November 15, 2021. Company management will host a corresponding conference call at 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time.

Science 37 to Report Third Quarter 2021 Financial Results on November 15, 2021

LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today's more agile clinical trials, and CMIC HOLDINGS Co., Ltd. (“CMIC”), the largest CRO in Japan today announced a partnership to further decentralized clinical trials and to help speed the development of treatments. In this collaboration, CMIC will use Science 37's clinical trial Operating System and its end-to-end technology platform to help orchestrate workflows, generate evidence and harmonize data for global decentralized studies—helping speed study timelines.

Science 37® and CMIC Announce Partnership to Advance Decentralized Clinical Trials in Japan/APAC and Speed Drug Development

LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today's more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science 37's clinical trial Operating System with its end-to-end technology platform for eConsent, electronic data capture, patient management, telemedicine and mobile nurse operations.

Science 37® and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment

The stock price of Science 37 (NASDAQ: SNCE) increased substantially this past week. This is why it happened.

SNCE Stock: Why It Substantially Increased This Week

News for Science 37 Holdings Stock (SNCE)